Analyst Price Targets — CSTL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 29, 2026 8:40 pm | Paul Knight | KeyBanc | $50.00 | $39.16 | TheFly | Castle Biosciences price target raised to $50 from $36 at KeyBanc |
| January 26, 2026 2:35 pm | Subbu Nambi | Guggenheim | $47.00 | $43.08 | TheFly | Castle Biosciences price target raised to $47 from $43 at Guggenheim |
| January 12, 2026 2:17 pm | — | Lake Street | $52.00 | $40.14 | TheFly | Castle Biosciences price target raised to $52 from $35 at Lake Street |
| January 5, 2026 2:26 pm | — | Guggenheim | $43.00 | $37.77 | TheFly | Castle Biosciences price target raised to $43 from $30 at Guggenheim |
| December 22, 2025 11:54 am | — | Canaccord Genuity | $50.00 | $39.44 | TheFly | Castle Biosciences price target raised to $50 from $37 at Canaccord |
| December 12, 2025 12:23 pm | Mark Massaro | BTIG | $50.00 | $37.97 | TheFly | Castle Biosciences price target raised to $50 from $38 at BTIG |
| March 28, 2025 11:10 am | Subbu Nambi | Guggenheim | $30.00 | $20.10 | TheFly | Castle Biosciences price target lowered to $30 from $37 at Guggenheim |
| February 28, 2025 12:58 pm | — | Robert W. Baird | $37.00 | $21.68 | TheFly | Castle Biosciences price target raised to $37 from $36 at Baird |
| November 5, 2024 8:50 pm | Sung Ji Nam | BTIG | $45.00 | $31.15 | StreetInsider | Castle Biosciences (CSTL) PT Raised to $45 at BTIG |
| November 5, 2024 11:50 am | Catherine Schulte | Robert W. Baird | $39.00 | $32.80 | StreetInsider | Castle Biosciences (CSTL) PT Raised to $39 at Baird |
Latest News for CSTL
FRIENDSWOOD, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will host a grand opening celebration for its new corporate headquarters on Tuesday, March 24, 2026, at 3:00 p.m. Central time.
Shares of Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) gapped down before the market opened on Friday. The stock had previously closed at $31.88, but opened at $29.87. Castle Biosciences shares last traded at $30.2290, with a volume of 212,078 shares. Key Stories Impacting Castle Biosciences Here are the key news stories impacting
Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call Transcript
Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.32 per share a year ago.
2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million Conference call and webcast today at 4:30 p.m. ET FRIENDSWOOD, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CSTL.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.